Parabolic Drugs Stock Forecast for 2023 - 2025 - 2030
Updated on 05/09/2024
Parabolic Drugs Stock Forecast and Price Target
Given the average yearlong price target of 6.01 provided by prominent analysts over the past few months, there is a potential upside of approximately 5.44% from the last closing price in August, 2021 for Parabolic Drugs's stock if it is reached. This estimation is based on a high estimate of 6.73 and a low estimate of 5.35. If you want to invest in 533211 stock, you might also want to take a look at how its competitors are doing.
5.44% Upside
Parabolic Drugs Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Parabolic Drugs's Price has seen an increase, rising from 0.00 to 0.00. This represents a growth of 100.00%. Analysts predict that Parabolic Drugs's Fair Value will increase in the upcoming year, reaching 5.11. This would represent an increase of 100.00%. Over the next eight years, experts predict that Parabolic Drugs's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Stock Forecast | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.49k | Buy/Sell | Rp1.52k | 6.04% |
| CIPLA Stock Forecast | Cipla | Outperform |
18
|
Rp1.36k | Buy/Sell | Rp1.43k | 10.28% |
| ZYDUSLIFE Stock Forecast | Zydus Lifesciences | Outperform |
18
|
Rp968.20 | Buy/Sell | Rp655.25 | -10.40% |
| 500124 Stock Forecast | Dr. Reddy's Laboratories | Hold |
18
|
Rp5.88k | Buy/Sell | Rp5.67k | 3.08% |
| 500420 Stock Forecast | Torrent Pharmaceuticals | Outperform |
18
|
Rp2.52k | Buy/Sell | Rp2.13k | 11.03% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 500257 Stock Forecast | Lupin | Hold |
12
|
Rp1.58k | Buy/Sell | Rp1.11k | 0.68% |
| AUROPHARMA Stock Forecast | Aurobindo Pharma | Outperform |
18
|
Rp1.12k | Buy/Sell | Rp1.09k | 5.44% |
| 500488 Stock Forecast | Abbott India | Outperform |
18
|
Rp25.56k | Buy/Sell | Rp24.75k | 17.38% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 500660 Stock Forecast | GlaxoSmithKline Pharmaceutical... | Hold |
18
|
Rp1.97k | Buy/Sell | Rp1.78k | 6.96% |
| IPCALAB Stock Forecast | Ipca Laboratories | Hold |
18
|
Rp1.28k | Buy/Sell | Rp987.00 | -10.73% |
| GLENMARK Stock Forecast | Glenmark Pharmaceuticals | Outperform |
18
|
Rp999.65 | Buy/Sell | Rp767.80 | -9.52% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 506943 Stock Forecast | J. B. Chemicals & Pharmaceutic... | Outperform |
18
|
Rp1.77k | Buy/Sell | Rp1.89k | 10.01% |
| AJANTPHARM Stock Forecast | Ajanta Pharma | Outperform |
18
|
Rp2.41k | Buy/Sell | Rp1.95k | 6.03% |
| 500302 Stock Forecast | Piramal Enterprises | Hold |
18
|
Rp816.05 | Buy/Sell | Rp1.11k | 16.41% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| APLLTD Stock Forecast | Alembic Pharmaceuticals | Hold |
16
|
Rp1.00k | Buy/Sell | Rp742.44 | -8.62% |
| PFIZER Stock Forecast | Pfizer | Outperform |
18
|
Rp4.30k | Buy/Sell | Rp4.53k | 14.64% |
| 500674 Stock Forecast | Sanofi India | Outperform |
18
|
Rp8.09k | Buy/Sell | Rp8.61k | 13.29% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NATCOPHARM Stock Forecast | NATCO Pharma | Outperform |
16
|
Rp969.60 | Buy/Sell | Rp822.45 | 3.65% |
| 506820 Stock Forecast | AstraZeneca Pharma India | - |
18
|
Rp5.13k | Buy/Sell | Rp0.00 | -100.00% |
| 524742 Stock Forecast | Caplin Point Laboratories | Buy |
17
|
Rp1.27k | Buy/Sell | Rp1.47k | 21.10% |
Parabolic Drugs EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Parabolic Drugs's EPS has seen an increase, rising from 0.00 to 0.00. This represents a growth of 100.00%. Analysts predict that Parabolic Drugs's EPS will increase in the upcoming year, reaching 0.00. This would represent an increase of 100.00%. Over the next eight years, experts predict that Parabolic Drugs's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 532482 Stock Forecast | Granules India | Buy |
18
|
Rp392.05 | Buy/Sell | Rp381.00 | 22.43% |
| STAR Stock Forecast | Strides Pharma Science | Outperform |
9
|
Rp833.30 | Buy/Sell | Rp618.00 | -1.18% |
| 500126 Stock Forecast | Procter & Gamble Health | - |
17
|
Rp4.66k | Buy/Sell | Rp5.62k | -100.00% |
.jpg)